DJIA 17,265.99 0.00 0.00%
NASDAQ 4,593.43 0.00 0.00%
S&P 500 2,011.36 0.00 0.00%
market minute promo

5.22 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $5.22 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.39
Previous Close $5.22
Daily Range $5.16 - $5.42
52-Week Range $3.10 - $7.45
Market Cap $363.1M
P/E Ratio -8.72
Dividend (Yield) $0.00 (0.0%)
Volume 641,644
Average Daily Volume 913,301
Current FY EPS -$0.02

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog

US Stock Futures Signal Higher Start On Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q2 2014 Results - Earnings Call Transcript

Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 8, 2014

Will Progenics (PGNX) Disappoint this Earnings Season? - Analyst Blog

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

See More PGNX News...

PGNX's Top Competitors

PGNX $5.22 (0.00%)
Current stock: PGNX
AMGN $142.02 (0.00%)
Current stock: AMGN
GILD $105.93 (0.00%)
Current stock: GILD
BIIB $329.99 (0.00%)
Current stock: BIIB